Indian Review Revisits Legacy Effect of Gliclazide in Diabetes Management Dr. Kamal Kant Kohli21 Sep 2023 5:45 AM GMTTaking strong note of the effective glycemic control and vascular benefits shown by early intensive treatment with Gliclazide MR (modified release) in...
Linagliptin The Evergreen Gliptin: Indian Position Paper Highlights Wide Clinical Applicabilities of Linagliptin in T2DM Dr. Kamal Kant Kohli14 Sep 2023 6:15 AM GMTA recent position paper from India has reported that Linagliptin is clinically beneficial across a wide range of patients eliminating the need for...
ESC 2023 Reaffirms CV Safety of Sulphonylureas Agents Dr. Prem Aggarwal30 Aug 2023 6:00 AM GMTThe European Society of Cardiology (ESC) has released new guidelines for managing cardiovascular disease among patients with diabetes, simplifying...
ADA Releases Guidelines Update for Screening and Treatment NAFLD in Type 2 Diabetes, Check Out Details Dr. Kamal Kant Kohli28 July 2023 6:02 AM GMTUnderstanding the close interaction between Non-Alcoholic Fatty Liver Disease & Type 2 Diabetes, and continuously evolving evidence, the American...
Role of Multi-strain Probiotics in Gut Dysbiosis Associated with Long-term Use of Medications in Chronic Diseases: Practical Review Dr Sharma Ashok26 July 2023 5:45 AM GMTNumerous chronic diseases, including gastrointestinal, inflammatory, and metabolic disorders as well as cardiovascular, respiratory, and neurological...
Glimepiride Stands Tall on Cardiovascular Safety Again: Latest Update Dr. Prem Aggarwal9 Jun 2023 6:06 AM GMTThe epidemiologic link between diabetes & heart failure is well established, with a burden of heart failure among 22% of patients with diabetes...
A Novel Therapeutic Approach for Managing Hidden Epidemic of FLA1c in Patients with T2DM Dr. Kamal Kant Kohli31 May 2023 4:45 AM GMTNon-alcoholic fatty liver disease (NAFLD) affects up to one-third of the general population worldwide. Type 2 diabetes mellitus (T2DM) and obesity...
UKPDS and DCCT Legacy Effects: Importance of Early Treatment of Hyperglycemia Dr Shailesh Dixit1 Feb 2023 6:59 AM GMTPeople with diabetes benefit from better target glycemic control in the early years following diagnosis and can prevent threatening vascular...
RSSDI Releases Guidelines for Management of Hypertension in Diabetes Mellitus 2022 Dr. Kamal Kant Kohli21 Dec 2022 7:15 AM GMTCatering to the pressing need to outline an evidence and experience based comprehensive treatment yardstick, the first-ever Indian guideline for the...
Achieving Glycemic Control HbA1c less than 7 percent Linked to Reduction risk of Diabetes-Related Complications Dr. Anubha Srivastava19 Dec 2022 6:45 AM GMT Diabetes - metabolic disorder characterized by hyperglycemia, is a significant and pervasive health issue worldwide. Given its chronic nature and...
Once Daily Vildagliptin 100 mg sustained-release therapeutically safe, effective as Vildagliptin 50 mg twice daily add on to Metformin in Indian Diabetics Lalhmangaihkimi12 Aug 2022 7:00 AM GMTVildagliptin 100 mg sustained-release once daily is therapeutically safe and effective as Vildagliptin 50 mg tablet twice daily as an add-on to...
Role of Probiotics in PPI-induced Gastroparesis: A Review Dr Ananda Bagchi27 July 2022 7:00 AM GMTGastroparesis refers to a disorder of deranged digestive function of the proximal gastrointestinal tract with evidence of abnormally extended...
